Prestige Consumer Healthcare ROE 2010-2024 | PBH
Current and historical return on equity (ROE) values for Prestige Consumer Healthcare (PBH) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Prestige Consumer Healthcare ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2024-09-30 | $0.21B | $1.73B | 12.30% |
| 2024-06-30 | $0.21B | $1.68B | 12.67% |
| 2024-03-31 | $0.21B | $1.66B | 13.33% |
| 2023-12-31 | $-0.08B | $1.60B | -5.34% |
| 2023-09-30 | $-0.08B | $1.54B | -5.33% |
| 2023-06-30 | $-0.09B | $1.48B | -5.45% |
| 2023-03-31 | $-0.08B | $1.45B | -5.24% |
| 2022-12-31 | $0.21B | $1.69B | 12.98% |
| 2022-09-30 | $0.21B | $1.62B | 13.20% |
| 2022-06-30 | $0.20B | $1.59B | 13.15% |
| 2022-03-31 | $0.21B | $1.58B | 13.73% |
| 2021-12-31 | $0.19B | $1.52B | 13.14% |
| 2021-09-30 | $0.18B | $1.46B | 12.95% |
| 2021-06-30 | $0.18B | $1.42B | 13.40% |
| 2021-03-31 | $0.17B | $1.36B | 12.80% |
| 2020-12-31 | $0.17B | $1.32B | 13.36% |
| 2020-09-30 | $0.16B | $1.28B | 13.58% |
| 2020-06-30 | $0.15B | $1.23B | 13.03% |
| 2020-03-31 | $0.14B | $1.17B | 12.51% |
| 2019-12-31 | $-0.03B | $1.16B | -3.04% |
| 2019-09-30 | $-0.03B | $1.11B | -2.99% |
| 2019-06-30 | $-0.04B | $1.10B | -3.11% |
| 2019-03-31 | $-0.04B | $1.10B | -3.07% |
| 2018-12-31 | $0.06B | $1.23B | 5.29% |
| 2018-09-30 | $0.34B | $1.19B | 28.63% |
| 2018-06-30 | $0.34B | $1.16B | 30.53% |
| 2018-03-31 | $0.34B | $1.18B | 32.76% |
| 2017-12-31 | $0.39B | $1.22B | 41.21% |
| 2017-09-30 | $0.11B | $0.90B | 12.79% |
| 2017-06-30 | $0.11B | $0.86B | 13.39% |
| 2017-03-31 | $0.07B | $0.82B | 8.80% |
| 2016-12-31 | $0.07B | $0.80B | 9.42% |
| 2016-09-30 | $0.07B | $0.78B | 9.14% |
| 2016-06-30 | $0.07B | $0.74B | 9.42% |
| 2016-03-31 | $0.10B | $0.74B | 14.21% |
| 2015-12-31 | $0.11B | $0.72B | 16.31% |
| 2015-09-30 | $0.10B | $0.69B | 15.93% |
| 2015-06-30 | $0.09B | $0.66B | 13.95% |
| 2015-03-31 | $0.08B | $0.63B | 12.91% |
| 2014-12-31 | $0.07B | $0.61B | 11.90% |
| 2014-09-30 | $0.05B | $0.59B | 9.09% |
| 2014-06-30 | $0.07B | $0.59B | 12.35% |
| 2014-03-31 | $0.07B | $0.56B | 13.59% |
| 2013-12-31 | $0.08B | $0.54B | 14.74% |
| 2013-09-30 | $0.09B | $0.54B | 17.21% |
| 2013-06-30 | $0.07B | $0.50B | 15.15% |
| 2013-03-31 | $0.07B | $0.48B | 14.51% |
| 2012-12-31 | $0.05B | $0.46B | 10.72% |
| 2012-09-30 | $0.04B | $0.44B | 10.59% |
| 2012-06-30 | $0.04B | $0.42B | 9.42% |
| 2012-03-31 | $0.04B | $0.40B | 9.66% |
| 2011-12-31 | $0.04B | $0.40B | 11.48% |
| 2011-09-30 | $0.04B | $0.39B | 9.69% |
| 2011-06-30 | $0.03B | $0.38B | 9.41% |
| 2011-03-31 | $0.03B | $0.36B | 8.24% |
| 2010-12-31 | $0.03B | $0.36B | 7.56% |
| 2010-09-30 | $0.04B | $0.35B | 10.41% |
| 2010-06-30 | $0.03B | $0.34B | 10.41% |
| 2010-03-31 | $0.03B | $0.33B | 10.08% |
| 2009-12-31 | $-0.18B | $0.33B | -58.95% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.882B | $1.125B |
| Prestige Consumer Healthcare Inc. is a consumer healthcare products company. Its diverse portfolio of brands include Monistat(R) and Summer's Eve(R) women's health products, BC(R) and Goody's(R) pain relievers, Clear Eyes(R) and TheraTears(R) eye care products, DenTek(R) specialty oral care products, Dramamine(R) motion sickness treatments, Fleet(R) enemas and glycerin suppositories, Chloraseptic(R) and Luden's(R) sore throat treatments and drops, Compound W(R) wart treatments, Little Remedies(R) pediatric over-the-counter products, Boudreaux's Butt Paste(R) diaper rash ointments, Nix(R) lice treatment, Debrox(R) earwax remover, Gaviscon(R) antacid in Canada, and Hydralyte(R) rehydration products and the Fess(R) line of nasal and sinus care products in Australia. Prestige Consumer Healthcare Inc., formerly known as Prestige Brands Holdings Inc., is based in Tarrytown, New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $196.826B | 25.11 |
| Stryker (SYK) | United States | $146.166B | 32.94 |
| Boston Scientific (BSX) | United States | $145.408B | 41.81 |
| EssilorLuxottica (ESLOY) | France | $115.383B | 0.00 |
| Medtronic (MDT) | Ireland | $112.944B | 16.78 |
| Lonza Group Ag (LZAGY) | Switzerland | $43.849B | 0.00 |
| Haleon (HLN) | United Kingdom | $41.827B | 27.18 |
| GE HealthCare Technologies (GEHC) | United States | $38.715B | 20.08 |
| ResMed (RMD) | United States | $35.199B | 28.92 |
| Terumo (TRUMY) | Japan | $27.980B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $24.250B | 18.56 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.811B | 13.89 |
| Insulet (PODD) | United States | $19.347B | 77.04 |
| Baxter (BAX) | United States | $15.818B | 10.29 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.057B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $9.586B | 32.58 |
| BellRing Brands (BRBR) | United States | $9.323B | 37.51 |
| Demant (WILYY) | Denmark | $8.735B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.360B | 14.78 |
| ICU Medical (ICUI) | United States | $4.012B | 38.20 |
| Haemonetics (HAE) | United States | $3.691B | 18.01 |
| Envista Holdings (NVST) | United States | $3.413B | 25.42 |
| Perrigo (PRGO) | Ireland | $3.252B | 9.57 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.807B | 18.07 |
| GN Store Nord (GNNDY) | Denmark | $2.585B | 16.58 |
| Neogen (NEOG) | United States | $2.508B | 28.90 |
| LeMaitre Vascular (LMAT) | United States | $2.227B | 54.13 |
| AtriCure (ATRC) | United States | $1.876B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.572B | 27.52 |
| AdaptHealth (AHCO) | United States | $1.416B | 10.11 |
| InMode (INMD) | Israel | $1.410B | 8.48 |
| BioLife Solutions (BLFS) | United States | $1.213B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.205B | 0.00 |
| Owens & Minor (OMI) | United States | $1.124B | 8.78 |
| Curaleaf Holdings (CURLF) | Canada | $0.981B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.843B | 14.87 |
| CeriBell (CBLL) | United States | $0.754B | 0.00 |
| Evolus (EOLS) | United States | $0.666B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.623B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.557B | 24.58 |
| Omeros (OMER) | United States | $0.541B | 0.00 |
| Surmodics (SRDX) | United States | $0.527B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.434B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.434B | 0.00 |
| ZimVie (ZIMV) | United States | $0.394B | 33.23 |
| Valneva SE (VALN) | France | $0.355B | 0.00 |
| Quanterix (QTRX) | United States | $0.342B | 0.00 |
| Cerus (CERS) | United States | $0.332B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.317B | 30.18 |
| Biote (BTMD) | United States | $0.306B | 6.71 |
| Sanara MedTech (SMTI) | United States | $0.285B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.272B | 18.25 |
| High Tide (HITI) | Canada | $0.250B | 103.00 |
| Zynex (ZYXI) | United States | $0.245B | 51.20 |
| Canopy Growth (CGC) | Canada | $0.237B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.226B | 3.18 |
| Aurora Cannabis (ACB) | Canada | $0.211B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.211B | 14.56 |
| Organigram Holdings (OGI) | Canada | $0.196B | 0.00 |
| Brainsway (BWAY) | Israel | $0.192B | 102.30 |
| MacroGenics (MGNX) | United States | $0.188B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.168B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.150B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.149B | 18.77 |
| Veru (VERU) | United States | $0.143B | 0.00 |
| Jin Medical (ZJYL) | China | $0.143B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.130B | 0.00 |
| Fonar (FONR) | United States | $0.096B | 10.87 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.092B | 0.00 |
| INLIF (INLF) | $0.078B | 0.00 | |
| InterCure (INCR) | Israel | $0.077B | 0.00 |
| Exagen (XGN) | United States | $0.070B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.069B | 35.33 |
| Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.058B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.056B | 0.00 |
| Apyx Medical (APYX) | United States | $0.052B | 0.00 |
| ImmuCell (ICCC) | United States | $0.049B | 0.00 |
| Modular Medical (MODD) | United States | $0.042B | 0.00 |
| Safety Shot (SHOT) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.017B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.008B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.006B | 0.00 |
| Agape ATP (ATPC) | $0.005B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.001B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 14.11 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |